Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety-Reference-Cited by-同舟云学术

Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety

Published:2011-07-26 Issue:9 Volume:24 Page:1420-1456
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Meanwell Nicholas A.¹

Affiliation:

1. Department of Medicinal Chemistry, Bristol Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx200211v

Reference105 articles.

1. Can the pharmaceutical industry reduce attrition rates?

2. Pharmaceutical Research and Manufacturers of America, Chart Pack, available athttp://www.phrma.org/sites/default/files/159/phrma_chart_pack.pdf.

3. Pharmaceutical Research and Manufacturers of America, Pharmaceutical Industry Profile 2011 (Washington, DC: PhRMA, March 2011) available athttp://www.phrma.org/sites/default/files/159/phrma_profile_2011_final.pdf.

4. Drugs, leads, and drug-likeness: an analysis of some recently launched drugs

5. A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs

Cited by 476 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Smoothened ligands based on the purine scaffold as potential agents for treating pancreatic cancer;Bioorganic Chemistry;2024-10

2. HPLC-UV method for the quantification of a novel indole-thiazole derivative (CS08) in nanoparticles;Microchemical Journal;2024-09

3. Estimation of acceptable daily intake values based on modeling and in vivo mutagenicity of NDSRIs of fluoxetine, duloxetine and atomoxetine;Regulatory Toxicology and Pharmacology;2024-09

4. Synthesis, in vitro and in silico screening of novel ferrocenyl substituted cyclohexenone and indazole derivatives as effective antimycobacterial agents;Journal of Molecular Structure;2024-09

5. Exploring the Anticancer Potential of Furanpydone A: A Computational Study on its Inhibition of MTHFD2 Across Diverse Cancer Cell Lines;Cell Biochemistry and Biophysics;2024-08-07